Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1637 1639 1675 1682 1684
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18274965 | ADAPTERS, ADAPTER LIGATION REAGENT, KIT, METHOD FOR CONSTRUCTING DNA LIBRARY AND METHOD FOR SEQUENCING GENE | Non-Final OA | BOE TECHNOLOGY GROUP CO., LTD. |
| 17922049 | DNA END REPAIR REAGENT AND KIT THEREOF, DNA LIBRARY CONSTRUCTION KIT, AND METHOD FOR CONSTRUCTING DNA LIBRARY | Final Rejection | BOE TECHNOLOGY GROUP CO., LTD. |
| 17773333 | A METHOD TO PREPARE PERSONALIZED TARGET-IRRELEVANT GUIDE RNA POOL FOR CRISPR | Final Rejection | Siemens Healthcare Diagnostics, Inc. |
| 17640475 | METHODS FOR IDENTIFICATION OF ANTIGEN BINDING SPECIFICITY OF ANTIBODIES | Non-Final OA | VANDERBILT UNIVERSITY |
| 18248215 | MULTIPLEXED METHYLATED DNA IMMUNOPRECIPITATION SEQUENCING TO STUDY DNA METHYLATION USING LOW AMOUNTS OF DNA | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17393994 | IN-SITU SPATIAL TRANSCRIPTOMICS AND PROTEOMICS | Final Rejection | Massachusetts Institute of Technology |
| 18558052 | MULTIPLEXED UNBIASED NUCLEIC ACID AMPLIFICATION METHOD | Non-Final OA | BECTON, DICKINSON AND COMPANY |
| 17098912 | MAGNETIC CAPTURE BEAD MEDIATED MOLECULAR BARCODING OF NUCLEIC ACID TARGETS IN SINGLE PARTICLES AND COMPOSITIONS FOR USE IN THE SAME | Final Rejection | Becton, Dickinson and Company |
| 17620605 | METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF | Final Rejection | Board of Regents, The University of Texas System |
| 17907166 | METHOD AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES | Final Rejection | Illumina, Inc. |
| 17768343 | Assays For Measuring Nucleic Acid Modifying Enzyme Activity | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 18414259 | LIGATION FREE METHODS OF NUCLEIC ACID LIBRARY PREPARATION | Non-Final OA | Arc Bio, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy